Most Liquid Life Sciences Tools & Services Companies

Cash And Equivalents
Cash And EquivalentsEfficiencyMarket RiskExp Return
1RVTY Revvity
1.22 B
(0.03)
 2.01 
(0.07)
2FTRE Fortrea Holdings
119.27 M
(0.28)
 4.28 
(1.19)
3CTOR Citius Oncology,
135.24
(0.08)
 7.34 
(0.57)
4TMO Thermo Fisher Scientific
8.52 B
(0.01)
 1.54 
(0.01)
5AZTA Azenta Inc
2.18 B
(0.19)
 2.77 
(0.52)
6ILMN Illumina
2.01 B
(0.28)
 2.73 
(0.75)
7QGEN Qiagen NV
1.89 B
(0.12)
 1.51 
(0.18)
8IQV IQVIA Holdings
1.22 B
(0.10)
 1.61 
(0.16)
9A Agilent Technologies
1.05 B
(0.13)
 1.64 
(0.22)
10CDT Conduit Pharmaceuticals
388.82 M
(0.14)
 16.66 
(2.30)
11TEM Tempus AI, Class
256.12 M
 0.12 
 8.33 
 1.03 
12BIO-B Bio Rad Laboratories
858.99 M
(0.24)
 4.12 
(0.98)
13PACB Pacific Biosciences of
834.34 M
(0.09)
 6.15 
(0.56)
14BRKR Bruker
733.6 M
(0.19)
 2.59 
(0.50)
15MRVI Maravai Lifesciences Holdings
617.45 M
(0.22)
 5.63 
(1.22)
16ICLR ICON PLC
616.63 M
(0.11)
 2.07 
(0.24)
17RGEN Repligen
596.51 M
(0.02)
 3.17 
(0.07)
18TXG 10X Genomics
499.73 M
(0.15)
 4.32 
(0.64)
19WAT Waters
481.39 M
 0.01 
 1.82 
 0.01 
20SEER Seer Inc
451.19 M
(0.21)
 2.02 
(0.41)
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.
Cash or Cash Equivalents are the most liquid of all assets found on the company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of the overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes. Cash equivalents represent current assets that are easily convertible to cash such as short term bonds, savings account, money market funds, or certificate of deposits (CDs). One of the important consideration companies make when classifying assets as cash equivalent is that investments they report on their balance sheets under current assets should have almost no risk of change in value over the next few months (usually three months).